| Trial ID: | L2873 |
| Source ID: | NCT03024944
|
| Associated Drug: |
18f-Thk-5351
|
| Title: |
TAU PET Imaging in Northern Manhattan Study of Metabolism and Mind
|
| Acronym: |
TAUPET
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus|Alzheimer Dementia
|
| Interventions: |
DRUG: 18F-THK-5351
|
| Outcome Measures: |
Primary: Amount of Tau Accumulation by Measuring Standardized Uptake Value Ratio (SUVR), The primary aim is to measure 18THK-5351 binding (SUVR) in medial temporal and inferior temporal cortex, cross-sectionally and longitudinally., 2 Years |
|
| Sponsor/Collaborators: |
Sponsor: Columbia University | Collaborators: National Institute on Aging (NIA)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
|
| Start Date: |
2017-12
|
| Completion Date: |
2020-01
|
| Results First Posted: |
|
| Last Update Posted: |
2017-12-29
|
| Locations: |
Columbia University Medical Center, New York, New York, 10032, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT03024944
|
